Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08881_nanopub.RAI--6HdbuICj28H97ynNPL2ay5D-ZQAy6pRXfoEBtoK0#assertion>. }
Showing items 1 to 21 of
21
with 100 items per page.
- drugbank:DB08881 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08881 label "Vemurafenib [drugbank:DB08881]" assertion.
- drugbank:DB08881 seeAlso DB08881 assertion.
- drugbank:DB08881 seeAlso vemurafenib.html assertion.
- drugbank:DB08881 seeAlso zelboraf-drug.htm assertion.
- drugbank:DB08881 identifier "drugbank:DB08881" assertion.
- drugbank:DB08881 description "Vemurafenib is a BRAF enzyme inhibitor developed by Plexxikon and Genentech for the treatment of late-stage melanoma. [Wikipedia] The cobas® 4800 BRAF B600 mutation test provided by Roche Molecular Systems is the diagnostic test to confirm eligibility for treatment. FDA approved on August 17, 2011 under the company Hoffmann La Roche." assertion.
- drugbank:DB08881 title "Vemurafenib" assertion.
- drugbank:DB08881 bio2rdf_vocabulary:identifier "DB08881" assertion.
- drugbank:DB08881 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08881 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08881" assertion.
- drugbank:DB08881 bio2rdf_vocabulary:x-identifiers.org DB08881 assertion.
- drugbank:DB08881 drugbank_vocabulary:drugbank-id "DB08881" assertion.
- drugbank:DB08881 drugbank_vocabulary:x-cas cas:918504-65-1 assertion.
- drugbank:DB08881 drugbank_vocabulary:x-ahfs ahfs:10:00 assertion.
- drugbank:DB08881 drugbank_vocabulary:x-atc atc:L01XE15 assertion.
- drugbank:DB08881 drugbank_vocabulary:x-chebi chebi:63637 assertion.
- drugbank:DB08881 drugbank_vocabulary:x-kegg kegg:D09996 assertion.
- drugbank:DB08881 drugbank_vocabulary:x-pharmgkb pharmgkb:PA165946873 assertion.
- drugbank:DB08881 drugbank_vocabulary:x-wikipedia wikipedia:Vemurafenib assertion.
- drugbank:DB08881 drugbank_vocabulary:x-ndc ndc:50242-090-01 assertion.